Volver al ranking

Similares a Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026

20 vecinos (text_768) · 548 views · HCPLive · Estados Unidos

Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels I #ats2026

HCPLive

@hcplivenews

548Estados Unidos
6Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients | ATS 2026

HCPLive

@hcplivenews

1.2KEstados Unidos85
3La Universitat se suma al Dia Europeu de Dèficit d'Alfa-1

Universitat de València

@universitatvalencia

481España86
5Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026

HCPLive

@hcplivenews

301Estados Unidos86
15Ralinepag Cuts PAH Clinical Worsening Risk by 55%, With Vallerie McLaughlin, MD | ATS 2026

HCPLive

@hcplivenews

290Estados Unidos84
19Aire limpio en casa: cómo proteger tu salud de toxinas invisibles 🍃🏠

Como Me Nutro

@comomenutro

272España83
10Sotatercept May Improve Right Heart Function in #pulmonaryhypertension

HCPLive

@hcplivenews

232Estados Unidos85
12Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD

HCPLive

@hcplivenews

198Estados Unidos85
1Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results

HCPLive

@hcplivenews

156Estados Unidos96
14Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026

HCPLive

@hcplivenews

117Estados Unidos84
13Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD

HCPLive

@hcplivenews

113Estados Unidos85
9Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension

HCPLive

@hcplivenews

112Estados Unidos85
7AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD

HCPLive

@hcplivenews

105Estados Unidos85
2Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results

HCPLive

@hcplivenews

82Estados Unidos95
20ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More | HCPLive Expert Interviews

HCPLive

@hcplivenews

70Estados Unidos83
16Functional Air Trapping May Predict Pneumothorax After BLVR

HCPLive

@hcplivenews

56Estados Unidos84
8ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews

HCPLive

@hcplivenews

55Estados Unidos85
4SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026

HCPLive

@hcplivenews

48Estados Unidos86
17Helping Patients Breathe Easier | Lynn Bingaman, CRNP at Geisinger

Geisinger

@geisingerhealth

45Estados Unidos84
11Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD

HCPLive

@hcplivenews

29Estados Unidos85
18APPs on the Front Lines of AATD Management

HCPLive

@hcplivenews

9Estados Unidos84